OpenAlex
PricingAboutJobs
Log inGet started
Work

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study

HTML

Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Current Medical Research and Opinion
DOI: 10.1185/030079905x74844
Authors: P. Weissman, B. J. Goldstein, J. Rosenstock, B. Waterhouse, A. R. Cobitz, M. J. Wooddell, L. J. Strow
Institutions: University of Miami, Thomas Jefferson University, GlaxoSmithKline (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: rosiglitazone, metformin, type 2 diabetes, combination therapy, dose escalation, HbA1c, glycemic control, fasting blood glucose, insulin resistance, adverse events, drug safety and tolerability, empire studies, thiazolidinediones, sulfonylureas
SDG: Good health and well-being

Open Access status: closed

Funder: GlaxoSmithKline
OpenAlex ID: W1972329806
FWCI: 3.729
Cites: 24
Cited by: 71
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security